Cargando…

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

Detalles Bibliográficos
Autores principales: Shi, Hui, Zheng, Peihao, Liu, Rui, Xu, Teng, Yang, Fan, Feng, Shaomei, Guo, Yuelu, Ma, Lixia, Liu, Haidi, Lei, Yang, Li, Ruiting, Deng, Biping, Hou, Shuling, Li, Yang, Zheng, Qinlong, Hu, Kai, Ke, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/
https://www.ncbi.nlm.nih.gov/pubmed/35901280
http://dx.doi.org/10.1182/bloodadvances.2021006845
_version_ 1784911243498225664
author Shi, Hui
Zheng, Peihao
Liu, Rui
Xu, Teng
Yang, Fan
Feng, Shaomei
Guo, Yuelu
Ma, Lixia
Liu, Haidi
Lei, Yang
Li, Ruiting
Deng, Biping
Hou, Shuling
Li, Yang
Zheng, Qinlong
Hu, Kai
Ke, Xiaoyan
author_facet Shi, Hui
Zheng, Peihao
Liu, Rui
Xu, Teng
Yang, Fan
Feng, Shaomei
Guo, Yuelu
Ma, Lixia
Liu, Haidi
Lei, Yang
Li, Ruiting
Deng, Biping
Hou, Shuling
Li, Yang
Zheng, Qinlong
Hu, Kai
Ke, Xiaoyan
author_sort Shi, Hui
collection PubMed
description
format Online
Article
Text
id pubmed-10034568
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-100345682023-03-24 Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL Shi, Hui Zheng, Peihao Liu, Rui Xu, Teng Yang, Fan Feng, Shaomei Guo, Yuelu Ma, Lixia Liu, Haidi Lei, Yang Li, Ruiting Deng, Biping Hou, Shuling Li, Yang Zheng, Qinlong Hu, Kai Ke, Xiaoyan Blood Adv Research Letter The American Society of Hematology 2022-07-30 /pmc/articles/PMC10034568/ /pubmed/35901280 http://dx.doi.org/10.1182/bloodadvances.2021006845 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Shi, Hui
Zheng, Peihao
Liu, Rui
Xu, Teng
Yang, Fan
Feng, Shaomei
Guo, Yuelu
Ma, Lixia
Liu, Haidi
Lei, Yang
Li, Ruiting
Deng, Biping
Hou, Shuling
Li, Yang
Zheng, Qinlong
Hu, Kai
Ke, Xiaoyan
Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title_full Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title_fullStr Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title_full_unstemmed Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title_short Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL
title_sort genetic landscapes and curative effect of car t-cell immunotherapy in patients with relapsed or refractory dlbcl
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034568/
https://www.ncbi.nlm.nih.gov/pubmed/35901280
http://dx.doi.org/10.1182/bloodadvances.2021006845
work_keys_str_mv AT shihui geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT zhengpeihao geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT liurui geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT xuteng geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT yangfan geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT fengshaomei geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT guoyuelu geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT malixia geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT liuhaidi geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT leiyang geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT liruiting geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT dengbiping geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT houshuling geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT liyang geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT zhengqinlong geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT hukai geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl
AT kexiaoyan geneticlandscapesandcurativeeffectofcartcellimmunotherapyinpatientswithrelapsedorrefractorydlbcl